Will S&P Global Ratings downgrade DOW to BBB- (or lower) by December 31, 2026?
Current Prediction
Why This Question Matters
An S&P downgrade to BBB- would tighten revolver pricing grids, signal covenant proximity, and materially constrain DOW's financial flexibility. Stress-scanner estimates 15-20% probability. Rating agencies typically act after sustained leverage above target without a visible path back; with net debt at 4.4x depressed EBITDA and 2026 projected as cash-burn, the surveillance risk is real. A downgrade would shift FUNDING_FRAGILITY from MODERATE toward STRETCHED in committee framing.
Prediction Distribution
Individual Predictions(9 runs)
Stress Scanner estimates 15-20% for BBB -> BB+. BBB -> BBB- is an intermediate notch that rating agencies use to signal concern without triggering HY-crossover mechanics. At 4.4x leverage on depressed EBITDA with 2026 cash-burn confirmed, S&P has grounds to act if they view the T2O trajectory skeptically. However, S&P typically waits for sustained deterioration (2+ quarters) and DOW's maturity profile to 2029 + liquidity ($3.8B cash + $10B revolver) provides cushion against immediate action. ~25% for the easier BBB- bar.
The committee placed FUNDING_FRAGILITY between MODERATE and STRETCHED — the label spread itself reflects concern. BBB- within 8 months implies negative watch first (typical 6-12 month lag). Rating agencies monitor chemicals cycle closely and DOW is among most-watched BBB credits. If Q1 2026 EBITDA comes in at guide ($750M) or below, surveillance action is plausible. Between 25-30%.
Historical base rate: BBB chemicals with 4.4x leverage on depressed EBITDA but investment-grade liquidity and maturity profile pushed out: approximately 15-25% probability of single-notch downgrade within 8 months. S&P has been patient with Dow historically (Dow Chemical 2009 analog). Liquidity is the pivotal protective factor. ~22%.
Base rate 15-25% for cyclical chemicals in trough without visible recovery. DOW has no recovery visibility until Q2/Q3 2026 earnings. If those disappoint, surveillance likely. If they meet or beat, S&P holds. ~25% probability of BBB- action.
DOW's $3.8B cash + $10B revolver + $1.2B NOVA + 2029 maturity pushout is exceptional liquidity for BBB. Rating agencies are unlikely to act on leverage alone given liquidity. Cycle extension would need to manifest clearly in Q1/Q2 EBITDA for surveillance to escalate. Probability ~22%.
Rating outlook as of analysis date not specified — if already on Negative Outlook, downgrade in 8 months is approximately 30-40% probability. If Stable, probability drops to 15-20%. Assuming roughly even split of outlook possibilities, ~25% weighted average.
Stress Scanner 15-20% for BBB -> BB+. BBB- is easier step, ~25%. Liquidity cushion delays action but leverage elevated. Committee stretch.
BBB- is intermediate notch. Probability higher than BB+ (which is HY crossover). ~25% given cycle pressure and elevated leverage.
Liquidity exceptional for BBB. Leverage elevated but cycle framing holds. ~22-25% probability. S&P history with Dow suggests patience.
Resolution Criteria
Resolves YES if S&P Global Ratings lowers DOW Inc.'s senior unsecured credit rating to BBB- (or any lower rating) at any point before 2026-12-31, as disclosed in an S&P research report, DOW 8-K, or bond prospectus. Resolves NO if the rating remains BBB or higher through 2026-12-31.
Resolution Source
S&P Global Ratings research, DOW 8-K filings, DOW IR disclosures
Source Trigger
S&P ratings downgrade to BBB- before 2026-12-31
Full multi-lens equity analysis